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ABSTRACT 
Background & Aims: Manganese (Mn) deposition could be responsible for the T1-weighted magnetic resonance 
signal hyperintensities observed in cirrhotic patients. These experiments were designed to assess the regional 
specificity of the Mn increases as well as their relationship to portal-systemic shunting or hepatobiliary dysfunction. 
Methods: Mn concentrations were measured in (1) brain samples from basal ganglia structures (pallidum, putamen, 
caudate nucleus) and cerebral cortical structures (frontal, occipital cortex) obtained at autopsy from 12 cirrhotic 
patients who died in hepatic coma and from 12 matched controls; and from (2) brain samples (caudate/putamen, 
globus pallidus, frontal cortex) from groups (n = 8) of rats either with end-to-side portacaval anastomosis, with 
biliary cirrhosis, or with fulminant hepatic failure as well as from sham-operated and normal rats. Results: Mn 
content was significantly increased in frontal cortex (by 38%), occipital cortex (by 55%), pallidum (by 186%), 
putamen (by 66%), and caudate (by 54%) of cirrhotic patients compared with controls. Brain Mn content did not 
correlate with patient age, etiology of cirrhosis, or history of chronic hepatic encephalopathy. In cirrhotic and 
portacaval-shunted rats, Mn content was increased in pallidum (by 27% and 57%, respectively) and in 
caudate/putamen (by 57% and 67%, respectively) compared with control groups. Mn concentration in pallidum was 
significantly higher in portacaval-shunted rats than in cirrhotic rats. No significant changes in brain Mn 
concentrations were observed in rats with acute liver failure. Conclusions: These findings suggest that brain Mn 
deposition results both from portal-systemic shunting and from liver dysfunction. 
Abbreviations MR , magnetic resonance; MRI , MR imaging 
INTRODUCTION 
Pallidal signal hyperintensity on magnetic resonance imaging (MRI) has been observed in most cirrhotic patients.1 
Increasing evidence suggests that accumulation of manganese could best explain this finding. Pallidal samples 
obtained at autopsy from cirrhotic patients who died in hepatic encephalopathy contain up to 7-fold increased 
manganese content.2 Histological examination of these samples excluded other potential causes of MRI signal 
hyperintensities. Furthermore, similar pallidal images have been observed in patients receiving manganese as part 
of total parenteral nutrition, and hyperintensities disappeared after cessation of manganese administration.3 and 4 
We previously reported significant positive correlations between blood manganese, pallidal index (a measure of the 
degree of magnetic resonance [MR] signal hyperintensity), and the presence of portal-systemic shunting in cirrhotic 
patients.5 However, studies attempting to correlate neurological symptoms with MR signal hyperintensities have so 
far yielded conflicting results.5, 6, 7, 8 and 9 These inconsistencies could result from the large variability in patient 
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population as well as the different methods of evaluation of neuropsychological status. The aims of the present series 
of experiments were (1) to measure the regional selectivity of manganese accumulation in the brains of cirrhotic 
patients compared with appropriate material from matched-controls; and (2) to determine the relative influence of 
portal-systemic shunting and cholestasis (both factors being suggested as major determinants for brain manganese 
deposition) on manganese accumulation in the brains of rats with chronic liver failure. 
MATERIALS AND METHODS 
Human studies 
Brain samples were obtained from 12 cirrhotic patients who died in hepatic coma and 12 control subjects who had 
no hepatic, neurological, or psychiatric disorders at the time of death and were matched for age, sex, and autopsy 
delay times. In no cases had patients or control subjects received total parenteral nutrition before death. Brain 
dissection was performed using a ceramic knife according to a standardized dissection protocol.10 Brain samples 
were frozen at −80°C until time of assay. Manganese was measured in the following brain regions: frontal cortex 
(from superior frontal gyrus), occipital cortex (from occipital gyrus), globus pallidus, putamen, and caudate nucleus. 
Rat studie 
Animals 
Five groups of male Sprague–Dawley rats (250–300 g) were evaluated. Group 1 (n = 8) consisted of normal rats. 
Group 2 (n = 8) included rats with end-to-side portacaval shunt performed according to the guidelines of Lee and 
Fisher11; rats underwent a laparotomy, and the inferior vena cava and portal vein were isolated. The inferior vena 
cava was partially clamped, and an elliptical piece of vein, 1.5 times the portal vein diameter, was cut and removed. 
The portal vein was ligated and cut, and an end-to-side anastomosis was performed under a dissecting microscope. 
Total surgery time was 15 minutes. Group 3 (n = 8) included sham-operated control rats matched for weight; a 
laparotomy was performed and the inferior vena cava and portal vein were isolated and occluded for 15 minutes. 
Studies in portacaval-shunted and sham-operated rats were performed 4 weeks after surgery. Group 4 (n = 8) were 
rats with secondary biliary cirrhosis induced by intracholedochal injection of formalin followed by bile duct ligation 
as described previously.12 These animals were studied 6 weeks after surgery. Group 5 (n = 8) consisted of rats with 
acute liver failure induced by a combination of portacaval anastomosis (as previously described above) followed 24 
hours later by hepatic artery ligation.13 Blood glucose levels were monitored and maintained at normal levels in all 
animals. Body temperature was monitored using a rectal thermometer probe and maintained at 37°C using a heat 
lamp if necessary. These rats were studied 15–18 hours after devascularization at coma stage of encephalopathy. All 
groups of rats were anesthesized with halothane throughout the surgery; postoperatively, animals were allowed to 
recover in individual cages under constant conditions of temperature, humidity, and light cycles, with free access to 
standard rat chow and water. 
Rats were killed by decapitation, and brains were quickly removed and dissected with nonmetallic surgical 
instruments. Manganese was measured in the following brain regions: frontal cortex, globus pallidus, and 
caudate/putamen. 
Biochemisty 
Blood samples were obtained after death of rats by decapitation. The following biochemical tests were performed 
using routine techniques: serum bilirubin, aspartate aminotransferase, alanine aminotransferase, albumin, and 
alkaline phosphatase. Blood ammonia was measured using an ion-exchange method followed by a colorimetric 
measurement of isolated ammonia nitrogen with the Berthelot phenate-hydrochlorate reaction.14 
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Portosystemic shunting 
Portosystemic shunting was evaluated in the group of rats with biliary cirrhosis. After injection of 141cerium-
radiolabeled microspheres in the mesenteric vein, portosystemic shunting was calculated from the ratio between 
lung and liver radioactivities as described previously.15 
Manganese 
Manganese was measured in brain tissue using neutron activation analysis.16 Briefly, neutron activation analysis is a 
2-step technique. The first step involves the tissue being irradiated with the neutron flux of a nuclear reactor. 
Neutrons are then captured by the manganese nuclei and subsequently become radioactive. Once removed from the 
nuclear reactor, radiation is emitted as gamma rays. The second step involves detection and measurement of the 
energy emitted from the gamma rays. This measurement gives the total amount of the manganese in the sample and, 
divided by the sample weight, results in the average concentration of manganese per gram of tissue. 
Statistical calculations 
Results are expressed as mean ± SEM. In human and rat studies, comparison between and within groups were made 
using two-way repeated-measures analysis of variance with the Tukey post hoc test. In rats, the biochemical studies 
were compared between groups using a one-way analysis of variance with the Tukey post hoc test. Correlations 
were evaluated using the Pearson's rtest. The level of statistical significance was set at P < 0.05. 
RESULTS 
Human studies 
Patient characteristics (cirrhotics and controls) are summarized in Table 1.  
Table 1. Patient characteristics 
 
Controls (n = 12) 
 
Cirrhotics (n = 12) 
 
Age (yr) 64.3 ± 3.7 
 
60.6 ± 2.5 
 
Sex (M/F) 10/2 
 
9/3 
 
Diagnosis Respiratory failure 3 Alcoholic cirrhosis 7 
 
Myocardial infarction 3 B viral cirrhosis 3 
 
Septic shock 2 C viral cirrhosis 1 
   
Cryptogenic cirrhosis 1 
 
Lung cancer 2 
  
 
Aortic aneurysm 1 
  
 
Multiorgan failure 1 
  
Delay between death and autopsy (h) 13 ± 2 
 
13 ± 4 
 
Groups were rigorously matched for age, sex, and time between death and sample freezing. 
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As shown in Figure 1, in both controls and cirrhotics, brain manganese concentrations were higher in basal ganglia 
structures (pallidum, putamen, and caudate nucleus) than in cortical areas (P < 0.001).  
 
Fig. 1. Manganese concentration in postmortem human brain tissue. Data are expressed as mean ± SEM. *P < 
0.05, statistically different from controls. 
In cirrhotics, a general increase in brain regional manganese concentration was observed compared with controls; 
manganese accumulation was much more pronounced in pallidum (+186%; 4.04 ± 1.54 vs. 1.41 ± 0.91 μg · g−1 · wet 
wt−1 in cirrhotics and controls, respectively; P < 0.001) and putamen (+66%; 1.48 ± 0.14 vs. 0.89 ± 0.12 μg · g−1 · wet 
wt−1; P < 0.05), and caudate nucleus (+54%; 0.88 ± 0.07 vs. 0.57 ± 0.06 μg · g−1 · wet wt−1; P < 0.05). Increased brain 
manganese content did not correlate with patient age, etiology of cirrhosis, or history of recurrent hepatic 
encephalopathy (6 patients). 
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Rat studies 
Characteristics of the 5 study groups are summarized in Table 2.  
Table 2. Characteristics of rat study groups 
 
Weight (g) 
Bilirubin 
(mg/dL) 
AST (IU/L) 
ALT 
(IU/L) 
ALP (IU/L) ALB ( g/L) 
Ammonia 
(μg/dL) 
PSS 
(%) 
PP (mm 
Hg) 
Controls (n = 
8) 
355 ± 25 3.1 ± 0.7 155 ± 16 55 ± 3 178 ± 21 25.3 ± 0.6 181 ± 5 — — 
Sham (n = 8) 356 ± 9 1.8 ± 0.2 202 ± 28 62 ± 4 191 ± 11 24.9 ± 0.6 120 ± 4 — — 
PCS (n = 8) 281 ± 10 2.4 ± 0.3 149 ± 13 58 ± 4 241 ± 18 23.6 ± 0.4 232 ± 16a — — 
Cirrhotics (n 
= 8) 
420 ± 11 117 ± 11b 493 ± 51b 90 ± 8a 256 ± 41 14.5 ± 0.7b 268 ± 21b 57 ± 10 18.5 ± 0.6 
ALF (n = 8) 218 ± 4 39 ± 4b 
15071 ± 
3340b 
7137 ± 
2471b 
400 ± 25b 25.5 ± 0.6 452 ± 20b — — 
aP < 0.05 bP < 0.01; significantly different from controls and sham groups. 
NOTE. Results given as mean ± SEM.PCS, portacaval shunt; ALF, acute liver failure (devascularization); AST, 
aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; ALB, albumin; PSS, portal-
systemic shunting; PP, portal pressure. 
Serum bilirubin levels were higher in cirrhotic rats (38-fold) and in hepatic devascularized rats (13-fold) compared 
with control groups of animals. Serum transaminase (aspartate and alanine) levels were also elevated in these rats, 
particularly in hepatic devascularized rats. Serum albumin level was significantly lower only in cirrhotic rats, with a 
43% decrease compared with controls. Alkaline phosphatase level was increased only in rats with acute liver failure 
with a 125% increase compared with controls. Blood ammonia was elevated in all 3 experimental liver failure 
groups of rats, with acute liver failure rats demonstrating the highest degree of hyperammonemia. 
Portal-systemic shunting was found to be 57% ± 10% in cirrhotic rats with a range from 29% to 100%. Portal 
hypertension was found in cirrhotic rats with an average portal pressure of 18.5 mm Hg. 
In all experimental groups except sham-operated animals, manganese content was higher in globus pallidus than in 
other brain regions (P < 0.001; Figure 2).  
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Fig. 2. Manganese concentration in rat brain tissue. Data are expressed as mean ± SEM. *P < 0.05, statistically 
different from controls and shams; oP < 0.05, statistically different between portacaval-shunted (PCS) and 
cirrhotic rats. ALF, acute liver failure. 
Brain manganese levels were higher in cirrhotic and portacaval-shunted rats than in the other 3 experimental 
groups (P < 0.001). In cirrhotic and portacaval-shunted rats, manganese content (in μg · g−1 · wet wt−1) was increased 
compared with normal rats in pallidum (by 27%: 0.85 ± 0.06 vs. 0.67 ± 0.06, P < 0.05; by 57%: 1.05 ± 0.07 vs. 0.67 ± 
0.06, P < 0.001, respectively); in caudate/putamen (by 57%: 0.66 ± 0.04 vs. 0.42 ± 0.01, P < 0.005; by 67%: 0.70 ± 
0.03 vs. 0.42 ± 0.01, P < 0.001); and in frontal cortex (by 41%: 0.65 ± 0.11 vs. 0.46 ± 0.01, P < 0.05; by 47%: 0.68 ± 
0.02 vs. 0.46 ± 0.01, P < 0.05). Furthermore, pallidal manganese concentrations were higher in portacaval-shunted 
rats than cirrhotic rats (by 23%: 1.05 ± 0.07 vs. 0.85 ± 0.06 μg · g−1 · wet wt−1; P < 0.05). In contrast, no significant 
changes could be shown in any brain regions of rats with acute liver failure compared with control animals. 
In cirrhotic rats, no significant correlation was observed between either serum albumin, serum bilirubin, serum 
transaminase, and alkaline phosphatase levels, blood ammonia or portal pressure, and brain manganese 
concentrations. However, the degree of portal-systemic shunting was correlated with pallidal manganese 
concentration (r = 0.72; P < 0.05). 
DISCUSSION 
This study confirms and extends previous reports of increased pallidal manganese concentrations in cirrhotic 
patients.17 and 18 The results also show that increased manganese in brain is a region-selective phenomenon with 
concentrations being highest in globus pallidus > putamen > caudate nucleus >> cerebral cortex in these patients. 
It has been suggested that selective manganese deposition in the pallidum could be the cause of the high signal 
intensity in T1-weighted images that has been consistently reported in most cirrhotic patients.1, 5, 6, 7, 8, 9, 19 and 20 
Further evidence suggesting that MR pallidal hyperintensities are best explained by manganese deposition is 
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provided by observations in patients receiving long-term parenteral nutrition in whom typical pallidal images 
obtained during manganese supplementation disappeared after cessation of manganese administration.3 and 4 
Furthermore, exposure of nonhuman primates to manganese administered either by inhalation or intravenously 
resulted in selective pallidal hyperintensities on MRI.21 and 22 
A cause-effect relationship between chronic liver disease and region-selective brain manganese accumulation is 
supported by several clinical observations. For example, a patient with decompensated cirrhosis caused by the 
Alagille syndrome who manifested extrapyramidal symptoms and pallidal hyperintensity on MRI was found to have 
increased blood manganese concentrations; 2 months after liver transplantation, the extrapyramidal symptoms 
resolved, blood manganese level returned to normal, and pallidal MR signal hyperintensity disappeared.23 Other 
investigators have reported a similar disappearance of pallidal MR hyperintensities several months after liver 
transplantation in cirrhotic patients.7 
Possible mechanisms responsible for manganese accumulation in the pallidum of patients with cirrhosis include a 
decrease in elimination via biliary excretion and an increased systemic availability due to portal-systemic shunting. 
Average daily oral manganese intake is 2.5–3 mg. Only 1%–3.5% of this normally reaches the systemic circulation 
because ingested manganese is rapidly cleared by the liver and excreted into the bile.24 Cirrhosis is associated with a 
variable degree of cholestasis that can affect biliary manganese excretion. In addition, abnormalities of the 
microcirculation (capillarization of the sinusoids and/or intrahepatic shunting) are present in the cirrhotic liver. 
Alternatively (or additionally), increased blood manganese in cirrhotic patients could result from the presence of 
portal-systemic collaterals produced either spontaneously or after surgical portocaval anastomosis or transjugular 
intrahepatic portosystemic shunt. 
To assess the relative importance of portal-systemic shunting and hepatobiliary dysfunction in the phenomenon of 
increased brain manganese in liver failure, we made use of animal models of portal-systemic shunting, of cholestasis 
associated with chronic liver failure, and of acute liver failure, a condition associated with neither cholestasis nor 
portal-systemic shunting. Both shunting and chronic cholestasis resulted in significant region-selective brain 
manganese accumulation. 
In rats with biliary cirrhosis, there was a combination of chronic cholestasis, as evidenced by increased serum 
bilirubin and alkaline phosphatase levels, of liver function impairment as shown by decreased serum albumin levels, 
and of spontaneous shunting. All these factors potentially contribute to manganese accumulation in the brain. 
Pallidal manganese concentrations were highest in shunted rats and correlated with the degree of portal-systemic 
shunting in cirrhotic rats, which confirms the notion that shunting is a major determinant of manganese 
accumulation in the brain. We observed in a previous study that blood manganese concentrations were particularly 
elevated in cirrhotic patients with previous portacaval shunts.5 Furthermore, T1-weighted MR signal intensity in 
pallidum significantly increased after transjugular portosystemic shunt placement but not after elective 
sclerotherapy in similar patients.25 Pallidal signal hyperintensity26 on MRI was previously reported in a child with 
patent ductus venosus in the absence of significant liver disease. 
Although evidence for a link between brain manganese deposition and MRI signal hyperintensities is convincing, a 
pathophysiological role for brain manganese deposition in the neurological symptoms in patients with liver disease 
and/or portosystemic shunts remains to be demonstrated. Manganese toxicity had previously been reported in 
miners after a prolonged exposure to manganese dust, resulting in extrapyramidal symptoms resembling 
Parkinson's disease.27 In cirrhotic patients, a high incidence of extrapyramidal symptoms, in particular rigidity, 
similar to that observed in Parkinson's disease, is observed when a detailed and careful neurological evaluation is 
performed.5 and 25 However, recent reports evaluating the relationship between blood manganese, pallidal 
hyperintensity, and neurological symptoms have yielded conflicting results.5, 6, 7, 8 and 9 These discrepancies may result 
from the fact that blood manganese levels do not accurately reflect concentrations of the metal in the brain. 
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In summary, region-selective increases in brain manganese concentration were observed in cirrhotic patients and in 
rats with either biliary cirrhosis or portacaval shunts. Brain manganese concentrations were particularly high in the 
pallidum of portacaval-shunted rats. These findings suggest that pallidal manganese accumulation observed in 
cirrhotic patients results from both portal-systemic shunting and impaired hepatobiliary elimination. Future studies 
in portacaval-shunted and cirrhotic rats could be useful in the evaluation of the potential of chelating agents to 
reverse manganese brain overload in chronic liver failure. 
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